A proposal for an evaluation model of pharmaceutical services for malaria.
Malaria is a serious public health problem in over 90 countries worldwide. In Brazil the disease is prevalent in the Amazon and the control rationale is based on early diagnosis and treatment. Quality pharmaceutical services are considered a key element for control. A proposal for evaluating pharmaceutical services for malaria is presented here. A theoretical outline composed of a logical model and an indicator framework is discussed and strives to establish a basis for assessment and judgment of the way in which these services are actually delivered. The aim is to contribute to the understanding of pharmaceutical services for malaria and other endemic diseases, complying with the directives of the Brazilian National Medicines Policy.
Osorio-de-Castro
Claudia Garcia Serpa
CG
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil. claudia.osorio@ensp.fiocruz.br
Chaves
Gabriela Costa
GC
Ruiz
Adriana Mendoza
AM
Miranda
Elaine Silva
ES
Campos
Mônica Rodrigues
MR
Suárez-Mútis
Martha Cecília
MC
Freitas
Letícia Figueira
LF
D000962:Antimalarials / Q000627:therapeutic use; D001938:Brazil / Q000453:epidemiology; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D019353:Endemic Diseases; D006291:Health Policy; D006801:Humans; D008288:Malaria / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D008962:Models, Theoretical; D009313:National Health Programs / Q000592:standards* / Q000706:statistics & numerical data; D010593:Pharmaceutical Services / Q000592:standards* / Q000706:statistics & numerical data / Q000600:supply & distribution; D015397:Program Evaluation / Q000379:methods*; D011786:Quality Control
D000962:Antimalarials